Tamoxifen-associated steatohepatitis--report of three cases

J Hepatol. 1995 Jul;23(1):95-7. doi: 10.1016/0168-8278(95)80316-5.

Abstract

The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Aged
  • Biopsy
  • Breast Neoplasms / drug therapy
  • Chemical and Drug Induced Liver Injury / diagnosis
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / pathology
  • Female
  • Humans
  • Liver / pathology
  • Middle Aged
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Tamoxifen